However, these side effects are often temporary and manageable
Weight loss drugs from the same manufacturer tend to be priced at a premium over diabetes versions of similar drugs
Diabetes, Obesity and Metabolism (January 2026), TRIUMPH-1 is structured as a basket trial with nested obstructive-sleep-apnea and osteoarthritis protocols, generating data across multiple indications simultaneously
tiny doses), but come with risks: inconsistent purity, potency, stability, and fewer regulatory guarantees
For a broader view of that research arc, our retatrutide clinical trials update covers the main findings and why the Phase 3 story matters
These studies are limited to laboratory and preclinical settings, and no conclusions regarding safety, efficacy, or application have been established